|
|
 ÇмúÇà»ç ¾È³»
| - ÀÏ ½Ã : 2012³â 4¿ù 22ÀÏ(ÀÏ) |
| - Àå ¼Ò : ¼¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ ¼Ò°´ç ¹× 1¼¼¹Ì³ª½Ç |
»çÀüµî·Ï
| - »çÀüµî·Ï ¸¶°¨ÀÏ : 2012³â 4¿ù 19ÀÏ(¸ñ) |
| - ÀԱݰèÁ : ±¹¹ÎÀºÇà 462237-01-002296 (¿¹±ÝÁÖ: ´ëÇÑ°ñ´Ù°øÁõÇÐȸ) |
| * »çÀüµî·Ï½Ã ¼º¸í, ¼Ò¼Ó, Àü°øºÐ¾ß, ÀÇ»ç¸éÇã¹øÈ£, ÁÖ¼Ò, ÀüȹøÈ£, Æѽº¹øÈ£, ¼Û±ÝÀÏÀ» ±âÀçÇØ Áֽñ⠹ٶø´Ï´Ù. |
|
Expert Meeting µî·Ïºñ
| ±¸ºÐ |
»çÀüµî·Ï |
| Á¤È¸¿ø/ºñȸ¿ø |
5¸¸¿ø |
Ãá°è¿¬¼ö°Á µî·Ïºñ (Æò»ýȸ¿øÀº µî·Ïºñ(¿¬¼ö°Á ¸¸) ¹«·á ÀÔ´Ï´Ù.)
| ±¸ ºÐ |
Á¤È¸¿ø |
ºñȸ¿ø |
|
»çÀüµî·Ï |
´çÀϵî·Ï |
»çÀüµî·Ï |
´çÀϵî·Ï |
ÀüÀÓÀÇ, °øº¸ÀÇ,
±ºÀÇ°ü,¼®»ç±ÞÀÌÇÏ ¿¬±¸¿ø |
3¸¸¿ø |
4¸¸¿ø |
4¸¸¿ø |
5¸¸¿ø |
°³¿øÀÇ, ºÀÁ÷ÀÇ, ¹Ú»ç±Þ ¿¬±¸¿ø
|
4¸¸¿ø |
5¸¸¿ø |
5¸¸¿ø |
6¸¸¿ø |
| Àü°øÀÇ |
1¸¸¿ø |
2¸¸¿ø |
ÆòÁ¡ : ´ëÇÑÀÇ»çÇùȸ 6Á¡, ´ëÇѹæ»ç¼±Çùȸ 2Á¡
ÇÁ·Î±×·¥
¢Â 2012³â Ãá°è¿¬¼ö°ÁÂ
Session I : °ñ´Ù°øÁõÀÇ ±âÃÊ
ÁÂÀå : ±èÁ¤±¸ (¼¿ïÀÇ´ë »êºÎÀΰú), ¿ø¿¹¿¬ (¾ÆÁÖÀÇ´ë Á¤Çü¿Ü°ú) |
| 09:00-09:20 |
°ñ´Ù°øÁõ ¹× °ñÀýÀÇ ¿ªÇÐ |
À̵¿¿Á (±¹¸³¾Ï¼¾ÅÍ »êºÎÀΰú) |
| 09:20-09:40 |
Sex-steroid and bone |
±è¼ºÈÆ (¿ï»êÀÇ´ë »êºÎÀΰú) |
| 09:40-10:00 |
°ñ´Ù°øÁõ Áø´ÜÀÇ ±âÃÊ |
¾ç½Â¿À
(µ¿³²±Ç¿øÀÚ·ÂÀÇÇпø ¿µ»óÀÇÇаú) |
| 10:00-10:30 |
Transforming Growth Factor Beta Enhances Osteoclast Support of
Bone Formation by Stimulating Wnt10b Production |
Kuniaki Ota
(Mayo Clinic, USA) |
Session II : º¸Çè±ÔÁ¤ ¹× °³¿ø°¡¿¡¼ÀÇ °ñ´Ù°øÁõ Áø·á
ÁÂÀå : ÃÖÈÆ (ÀÎÁ¦ÀÇ´ë »êºÎÀΰú) |
| 10:50-11:10 |
°³Á¤µÈ °ñ´Ù°øÁõ °ü·Ã º¸Çè±ÔÁ¤ |
±è¹üÅà (¾ÆÁÖÀÇ´ë °¡Á¤ÀÇÇаú) |
| 11:10-11:30 |
°³¿ø°¡¿¡¼ÀÇ °ñ´Ù°øÁõ Áø·á, ºí·ç¿À¼ÇÀΰ¡? |
¿ø¿µÁØ (¿¬¼¼¿ø³»°úÀÇ¿ø) |
Special Lecture
ÁÂÀå : ¿ø¿¹¿¬ (¾ÆÁÖÀÇ´ë Á¤Çü¿Ü°ú ) |
| 11:30-12:10 |
Strategic Management of Osteoporosis with Raloxifene |
Bruce Ettinger
(Kaiser Permanente, USA) |
| 12:10-12:30 |
Discussion |
|
Session III : °ñ´Ù°øÁõÀÇ ¾à¹°Ä¡·á
ÁÂÀå : ÃÖ¿õȯ (ÇѾçÀÇ´ë ³»ºÐºñ³»°ú), °º´¹® (¿ï»êÀÇ´ë »êºÎÀΰú) |
| 13:50-14:20 |
°ñ´Ù°øÁõ Ä¡·á¿¡¼ ComplianceÀÇ Á߿伺°ú
»õ·Î¿î Bisphosphonate Á¦Çü |
¹Ú¿¹¼ö (ÇѾçÀÇ´ë Á¤Çü¿Ü°ú) |
| 14:20-14:40 |
Ä®½·°ú ºñŸ¹Î D ¼·Ãë¿¡ °üÇÑ ÃÖ±Ù ³í¶õ |
ÃÖÇѼ® (µ¿±¹ÀÇ´ë ³»ºÐºñ³»°ú) |
| 14:40-15:00 |
Bisphosphonate ÀÇ ½ÇÁ¦ÀûÀÎ »ç¿ë Áõ·Ê |
±è¼¼È (°üµ¿ÀÇ´ë ³»ºÐºñ³»°ú) |
| 15:00-15:20 |
»õ·ÎÀÌ ÀÓ»ó¿¡¼ »ç¿ëµÉ New SermÀÇ Àå´ÜÁ¡ |
ÀÌÁö¿µ (°Ç±¹ÀÇ´ë »êºÎÀΰú) |
Session IV : ´ëÇ¥ÀûÀÎ °ñ´Ù°øÁõ¼º °ñÀýÀÇ ÀÓ»óÀû °íÂû
ÁÂÀå : ÀÌÁ߸í (±¹¸³Áß¾ÓÀÇ·á¿ø Á¤Çü¿Ü°ú), ½Åº´ÁØ (¼øõÇâÀÇ´ë Á¤Çü¿Ü°ú) |
| 15:40-16:00 |
Asymptomatic vertebral fracture ÀÇ ÀÇ¹Ì¿Í Áø´Ü |
ÀÌÀçÇù (¼¿ïÀÇ´ë Á¤Çü¿Ü°ú) |
| 16:00-16:20 |
ºñÁ¤Çü¿Ü°ú Àǻ簡 ±Ã±ÝÇØ Çϴ ôÃß°ñÀý Ä¡·á |
¾çÁØ¿µ (Ãæ³²ÀÇ´ë Á¤Çü¿Ü°ú) |
| 16:20-16:40 |
Hip fractureÀÇ ÀÇ¹Ì¿Í Áø´Ü |
¹®°æÈ£ (ÀÎÇÏÀÇ´ë Á¤Çü¿Ü°ú) |
| 16:40-17:00 |
Hip fractureÀÇ ¿¹¹æ°ú Ä¡·á |
Á¶À±Á¦ (°æÈñÀÇ´ë Á¤Çü¿Ü°ú) | ¢Â Á¦ 9ȸ Expert Meeting
Session I : Animal models of osteoporosis
ÁÂÀå : Á¤À±¼® (¾ÆÁÖÀÇ´ë ³»ºÐºñ³»°ú) |
| 09:00-09:30 |
Ovariectomy model, LPS or vitamin D injection model, healing model, transgenic and knock-out model |
Á¤Àçȯ
(°æºÏÀÇ´ë »ýÈÇм¼Æ÷»ý¹°Çаú) |
| 09:30-10:00 |
Steroid model, aging model, immobilization model |
Á¤À±¼® (¾ÆÁÖÀÇ´ë ³»ºÐºñ³»°ú) |
Session II : Arthritis and osteoporosis
ÁÂÀå : ¹Ú¿¹¼ö (ÇѾçÀÇ´ë Á¤Çü¿Ü°ú) |
| 10:20-10:30 |
Overview of arthritis and osteoporosis |
±èÅÂȯ (ÇѾçÀÇ´ë ·ù¸¶Æ¼½º³»°ú) |
| 10:30-10:50 |
Lessons from arthritis: clinical aspects |
½É½Âö (À»ÁöÀÇ´ë ·ù¸¶Æ¼½º³»°ú) |
| 10:50-11:10 |
Lessons from arthritis: basic aspects |
Á¶¹Ì¶ó
(°¡Å縯ÀÇ´ë ·ù¸¶Æ¼½º¿¬±¸¼¾ÅÍ) |
Session III : Bone (and joint) histomorphometry
ÁÂÀå : ÃÖÁ¦¿ë (°æºÏÀÇ´ë »ýÈÇм¼Æ÷»ý¹°Çаú) |
| 11:10-11:20 |
Introduction |
ÃÖÁ¦¿ë
(°æºÏÀÇ´ë »ýÈÇм¼Æ÷»ý¹°Çаú) |
| 11:20-11:40 |
°ÀÇ |
±èÁ¤Àº (°æºÏÀÇ´ë ºÐÀÚÀÇÇб³½Ç) |
| 11:40-12:10 |
½Ç½À |
ÀÓ°æÀº
(°æºÏÀÇ´ë »ýÈÇм¼Æ÷»ý¹°Çаú) |
| Special Lecture |
| 11:10-12:40 |
Identification and characterization of novel osteoclastogenic regulators |
¿¬¹Î¿µ (Univ. Tokyo, Japan) |
Session IV : Image-based microbiomechanics of bone
ÁÂÀå : ¿ø¿¹¿¬ (¾ÆÁÖÀÇ´ë Á¤Çü¿Ü°ú) |
| 13:40-13:50 |
Introduction of image based analysis in osteoporosis |
¿ø¿¹¿¬ (¾ÆÁÖÀÇ´ë Á¤Çü¿Ü°ú) |
| 13:50-14:10 |
Animal DXA PIXI-mus °ÀÇ ¹× ½Ç½À |
Á¤À±¼®,À̺´ÁÖ
(¾ÆÁÖÀÇ´ë ³»ºÐºñ³»°ú) |
| 14:10-14:50 |
Micro-CT image and analysis °ÀÇ ¹× ½Ç½À |
¹é¸íÇö
(¾ÆÁÖÀÇ´ë ÀÇ·á±â±âÀÓ»ó½ÃÇè¼¾ÅÍ) |
Session V : Cell culture studies including primary or established cell lines
ÁÂÀå : °íÁ¤Å (Àü³²´ë Ä¡Àü¿ø) |
| 15:10-15:40 |
Experimental methods in osteoblasts: Isolation and culture of
osteoblast cells, ALP acitivity, ALP and Alizarin Red staining etc. |
°íÁ¤Å (Àü³²´ë Ä¡Àü¿ø) |
| 15:40-16:10 |
Experimental methods in osteoclasts: Bone marrow preparation from
long bone, Osteoclast culture: primary cells from mice & human,
TRAP staining, Pit formation assay, Fusion assay, Survival assay,
Retrovirus infection |
±è³«¼º (Àü³²ÀÇ´ë ¾à¸®ÇÐ) |
Session VI : Genes and genetic studies in animals and human
ÁÂÀå : ±èÁ¤±¸ (¼¿ïÀÇ´ë »êºÎÀΰú) |
| 16:10-16:30 |
Genetic study in osteoporosis - approach and method
|
±èÈÆ (ÀÎõÀÇ·á¿ø »êºÎÀΰú) |
| 16:30-16:50 |
DNA extraction, Hypothesis, NIH searching, PCR primer orde,
agarose gel, DNA sequencing, Taqman assay, real-time PCR |
À̵¿¿Á (±¹¸³¾Ï¼¾ÅÍ »êºÎÀΰú) |
| 16:50-17:00 |
Interpretation of results including haplotyping, Hardy-Weinberg
equilibrium, Bonferroni |
À̵¿À± (»ï¼º¼¿ïº´¿ø »êºÎÀΰú) | | |
